Showing results (1091-1100 of 3,283) with videos related to
Sort By:
Pageof 329
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2012
Temporal evolution of remission following multiple sclerosis relapse and predictors of outcomeClaire L Hirst, Gillian Ingram, Trevor P Pickersgill, et al.Veterinary Microbiology|April 3, 1999
Preliminary studies on the prevalence of Mycoplasma bovis mastitis in dairy in cattle in AustraliaA Ghadersohi, R G Hirst, J Forbes-Faulkener, et al.The British Journal of Surgery|October 21, 2005
Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgeryA T Cohen, C Hirst, B Sherrill, et al.Endocrinology|April 1, 1995
Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cellsT Zakar, J J Hirst, J E Mijovic, et al.International Journal of Radiation Oncology, Biology, Physics|August 1, 1984
The effect of vitamin B6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: clinical and laboratory studiesC N Coleman, V K Hirst, D M Brown, et al.The Journal of Physiology|December 17, 2005
Propagation of slow waves in the guinea-pig gastric antrumG David S Hirst, A Pilar Garcia-Londoño, Frank R EdwardsDevelopment (Cambridge, England)|November 18, 2005
Arrow (LRP6) and Frizzled2 cooperate to degrade Wingless in Drosophila imaginal discsEugenia Piddini, Francis Marshall, Laurence Dubois, et al.British Journal of Pharmacology|July 19, 2005
Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscleVarsha Kanabar, Stuart J Hirst, Brian J O'Connor, et al.European Journal of Pharmacology|September 19, 2006
Selection of new chemical entities with decreased potential for adverse drug reactionsKevin B Park, Emma Dalton-Brown, Charlotte Hirst, et al.Pageof 329